Website: BioFluidica
Business Area(s): 

The heart of BioFluidica's CTC (Circulating Tumor Cells) system, is a highly efficient CTC capture bed, comprised of 50 to 500 sinusoidally-shaped channels. These channels are coated with antibodies, which isolate specific CTCs from whole blood. The antibodies are chemically immobilized onto the surfaces of the capture bed using BioFluidicas patented technology. 

Career Page(s): 
Headquarters, Screening facility #1
San Diego CA
United States
Advanced Research, Core Screening Facility #3
Lawrence KS
United States
Screening Facility Core #2
Research Triangle Park NC
United States